Katakura Industries (3001) Q4 2025 earnings summary

Executive summary

• Net sales/revenue rose to ¥40,652 million in FY2025, up 3.1% or ¥1,228 million year-over-year, driven by growth in machinery and real estate, offsetting declines in pharmaceuticals and textiles.

• Operating income increased by ¥1,731 million (42.0%) to ¥5,855 million, and profit attributable to owners of parent surged 63.5% to ¥5,763 million, aided by fixed asset sales.

• Operating income exceeded forecasts due to lower repair costs in Real Estate, despite net sales falling short in Textiles and Others.

• All major business segments except pharmaceuticals and textiles posted higher operating profits, with machinery showing the strongest rebound.

Financial highlights

• Operating income margin improved to 14.4% from 10.5% year-over-year.

• Cash and cash equivalents at year-end increased to ¥12,387 million from ¥9,214 million, a 34.4% rise.

• Capital expenditures rose to ¥2,994 million, up ¥812 million year-over-year.

• Equity ratio rose to 63.8%, reflecting a strengthened financial position.

• EPS increased to ¥180.73 from ¥107.72 year-over-year.

Outlook and guidance

• FY2026 net sales/revenue are forecast at ¥41,100 million (+1.1%), but operating income is expected to decrease by ¥355 million (−6.1%) to ¥5,500 million, and profit attributable to owners of parent is projected to decline by ¥563 million (−9.8%) to ¥5,200 million.

• Capital expenditures are expected to increase to ¥4,184 million in FY2026.

• Dividend forecast maintained at ¥60 per share for FY2026.

• Management expects continued cost pressures from inflation and currency, but will pursue structural reforms and growth investments, especially in functional fibers.